Stillingia lineata
Stillingia lineata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Stillingia lineata is a botanical species that has garnered significant scientific interest due to its unique biological properties. Recent studies have focused on investigating its potent antiviral activities against various pathogens. Specifically, research has highlighted the plant's potential effectiveness in combating the Chikungunya virus. These therapeutic benefits are primarily observed when utilizing specialized extracts derived from the plant's tissues. Consequently, this species represents a promising subject for the development of new antiviral treatments.
- Synonyms
- Sapium Lineatum
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Stillingia lineata is a distinctive plant that is recognized by several different regional monikers. It is most frequently referred to by its common name, Bois Jasmin. In certain areas, locals may also identify the species as Fangame. Additionally, the plant is known by the name Tanguin pays depending on the specific dialect or location. These varied names highlight the diverse linguistic ways this single species is categorized.
Sources: Catalogue of Life (COL)
Synonyms
Stillingia lineata is a plant species that is frequently identified in botanical literature under a different name. This specific taxon is also widely recognized by its synonym, Sapium lineatum. Understanding these naming conventions is essential for researchers tracking the plant's distribution and characteristics. While the nomenclature may shift between different scientific databases, both terms refer to the same organism. Therefore, recognizing these relationships ensures accuracy when studying its unique ecological role.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Stillingia lineata is a fascinating specimen belonging to the diverse kingdom Plantae. Within this vast biological group, it is classified under the class Equisetopsida. This plant further belongs to the order Malpighiales, showcasing its unique evolutionary placement. It is a member of the Euphorbiaceae family, which connects it to many other significant botanical species. Finally, it is identified by its specific genus, Stillingia, which defines its unique characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Stillingia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Stillingia lineata exhibits a wide and diverse geographic range that spans across multiple continents and island chains. In Africa, the species is found throughout the Western Indian Ocean, specifically inhabiting regions such as Mauritius and Réunion. Its reach extends significantly into tropical Asia, where it thrives near the Indo-China region and the South China Sea. Within the Malesia archipelago, the plant is well-established in areas like the Lesser Sunda Islands and the Maluku Islands. This broad distribution highlights the remarkable adaptability of the species across varied maritime and tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Stillingia lineata is a self-supporting species characterized by its distinct tree-like growth form. This plant can reach a maximum height of approximately 9 meters in its natural habitat. Its structural stability allows it to stand firmly as it matures into a significant component of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Stillingia lineata has demonstrated significant antiviral activity, particularly in its ability to combat the chikungunya virus. Research indicates that this plant is highly effective, achieving a notable selectivity index of 10.9 against the virus. Within the plant, specific isolated compounds like 12-deoxyphorbol-13(2″-methyl)butyrate have shown even greater potency and selectivity. Furthermore, certain derivatives from the species have exhibited strong selective antiviral effects against both human immunodeficiency virus-I and II. These findings position the plant as a promising candidate for the development of new natural antiviral drugs.
Compounds
Conditions
Stillingia lineata exhibits significant medicinal potential through its ability to treat the chikungunya virus. Research indicates that this plant demonstrates high anti-chikungunya activity, with specific isolated compounds serving as potent inhibitors of viral replication. Furthermore, the plant has shown effectiveness in treating glucose entrapment by demonstrating a concentration-dependent glucose diffusion retardation index. It also serves to treat α-glucosidase through significant inhibitory properties during in vitro studies. These diverse biological activities suggest that Stillingia lineata is a viable candidate for developing new antiviral and antidiabetic phytopharmaceuticals.
Preparations
Stillingia lineata is prepared as extracts for use in various pharmacological studies. Specifically, researchers utilized methanolic and aqueous versions of these extracts to test their medicinal properties. The study focused on how these liquid preparations interact with enzymes like α-glucosidase. These extracts demonstrated significant inhibitory activity and glucose entrapment capabilities during in vitro testing. Consequently, the preparation of Stillingia lineata into these specific forms allows for its potential application in diabetes management.